Screening of anti-HTLV-I antibody in the sera of pregnant women using an ELISA with recombinant antigen.
スポンサーリンク
概要
- 論文の詳細を見る
There are several methods to measure anti-HTLV-I antibody. ELISA and PA are widely use as screening tests for anti-HTLV-I antibody. However, commercially available kits (ELISA and PA tests) potentially contaminate some non-specific reactions. So the specimens, judged to be anti-HTLV-I antibody positive by screening test kits, are needed confirmation test (ie, indirect immunofluorescence and/ or western blotting) for specifity of anti-HTLV-I antibody. In the present study, using an ELISA with artificially synthesized recombinant antigen, we have examined anti-HTLV-I antibody in the sera of pregnant women. The results indicated that the presence or abscence of anti-HTLV-I antibody can be diagnosed by this newly developed ELISA system in the sera ofpregnant women without non-specific reactions.
- 近畿産科婦人科学会の論文
近畿産科婦人科学会 | 論文
- 当院における卵巣粘液性腺癌の治療経験の検討
- 婦人科癌末期の難治性イレウスに対する減圧目的の経皮的内視鏡的胃瘻造設について
- 子宮体癌の保存的治療後妊娠での前置癒着胎盤に対し内腸骨動脈バルーン留置下で帝王切開および子宮全摘術を施行した1例
- 当科の卵巣粘液性腺癌の治療成績 : ─リンパ節郭清の適応についての考察
- 妊娠糖尿病を合併した高度肥満妊婦の分娩誘発の1例